Cocoon is led by a committed group of physicians, scientists, and engineers dedicated to providing patients freedom from serious diseases.
CEO & Founder
Dr. Ailis Tweed-Kent is an up-and-coming entrepreneur and leader in the development of innovative medical technologies. With her education in medicine at Harvard Medical School (HMS) and residency in internal medicine at Massachusetts General Hospital (MGH), Ailis has first hand knowledge of the burden of disease. In 2013, Ailis was inspired by her patients to found Cocoon to develop innovative silk therapeutics leveraging silk as a materials science platform. Prior to Cocoon, she worked on the design, development, and delivery of diagnostic technologies for global health collaborating with organizations such as PEPFAR/Office of U.S. Global AIDS Coordinator, London School of Hygiene & Tropical Medicine, and the Global Health Delivery Project. She brings a multidisciplinary approach with a B.S. in Chemical Engineering from the University of Notre Dame. She was recently named to the Boston Business Journal’s 2017 Women to Watch in Science and Technology as well as the Boston MedTech’s 40 Under 40 Healthcare Innovators.